BERNENGO, Maria Grazia
BERNENGO, Maria Grazia
SCIENZE MEDICHE
1975-2011 Overall Survival, Disease Free Survival and Survival after Recurrence across gender in melanoma patients: what has changed?
2012-01-01 Simone Ribero; Pietro Quaglino; Martina Sanlorenzo; Simona Osella-Abate; Federica Marenco; Tiziana Nardò; Giuseppe Macripò; Maria Teresa Fierro; Maria Grazia Bernengo
Activity and safety of bexarotene as maintainance therapy in advanced/aggressive CTCL patients with stable disease or remission after systemic treatment: an observational multicenter trial from the GILC
2007-01-01 Pietro Quaglino; Maria Grazia Bernengo
Activity and safety of Bexarotene as maintenance therapy in CTCL patients (Mycosis Fungoides stage IIB-IV, Sezary Syndrome, peripheral T-cell lymphoma) with stable disease or remission after systemic treatments: A prospective multicenter trauil from the Italian Group of Cutaneous Lymphoma (GILC)
2011-01-01 Quaglino P;Pimpinelli N; Alaibac M; Quintini G; Bernengo MG
Alemtuzumab for the treatment of Sézary sindrome: clinical and immunological findings in 10 patients.
2006-01-01 Bernengo MG; Quaglino P; Comessatti A; Ortoncelli M; Novelli M; Fierro MT.
Alterazioni funzionali e fenotipiche dei polimorfonucleati nei pazienti affetti da dermatite atopica
2011-01-01 Banche G; Allizond V; Novelli M; Fierro MT; Mandras N; Murabito P; Quaglino P; Scalas D; Merlino C; Roana J; Tullio V; Bernengo MG; Cuffini AM
Alterazioni funzionali e fenotipiche dei polimorfonucleati nella sindrome di sezary
2009-01-01 G. Banche; M.T. Fierro; M. Novelli; V. Allizond; A. Comessatti; P. Quaglino; D. Scalas; C. Merlino; M.G. Bernengo; A Cuffini
Associazione di ciclofosfamide, vincristina e prednisone (COP) nel trattamento dei linfomi cutanei: 20 anni di follow-up.
1996-01-01 Fierro MT; Verrone A; Savoia P; Quaglino P; Doveil GC; Bernengo MG
Biological prognostic factors in advanced metastatic melanoma patients treated with chemoimmunotheraphy.
1997-01-01 Fierro MT; Quaglino P; Lisa F; Savoia P; Bernengo MG
Bullous pemphigoid is characterised by a reduction of skin-homing/circulating FOXP3+ Tregs and by a down-regulation of the IL-10 pathway
2012-01-01 Quaglino P; Antiga E; Novelli M; Nardò T; Fava P; Ponti R; Osella-Abate S; Caproni M; Fabbri P; Bernengo MG
Butyric acid effects on melanoma cell lines: apoptosis induction and cell cycle cytofluorimetric evaluation
1999-01-01 Salomone B; Cambieri I; Ponti R; Lisa F; Osella-Abate S; Ugazio E; Gasco M; Bernengo MG.
Caratterizzazione immunoistochimica e citofluorimetrica di una nuova linea di melanoma.
1998-01-01 Salomone B; Osella-Abate S; Fierro MT; Bernengo MG
CD26 (DPP-IV)- A useful marker in Sezary sindrome
1994-01-01 Novelli M; Fierro MT; Quaglino P; Lisa F; Doveil GC; Bernengo MG
CD26 expression on keratinocytes in normal skin, inflammatory skin diseases and cutaneous T-cell lymphomas (CTCL).
1995-01-01 Savoia P; Fierro MT; Novelli M; Verrone A; Quaglino P; Bernengo MG
CD26 expression on keratinocytes in normal skin, inflammatory skin diseases and cutaneous T-cell lymphomas (CTCL).
1995-01-01 Savoia P; Fierro MT; Novelli M; Verrone A; Quaglino P; Bernengo MG
CD3-CD56+ primary pure cutaneous lymphoma: a distinct entity in the spectrum of CD56 malignancies.
1996-01-01 Savoia P; Fierro MT; Novelli M; Verrone A; Quaglino P; Bernengo MG
CD4+CD26- evaluation is a more useful diagnostic parameter than CD4+CD7- in Sézary syndrome (SS).
1995-01-01 Novelli M; Quaglino P; Fierro MT; Savoia P; De Matteis A; Bernengo MG
CD4+CD26- evaluation is a more useful diagnostic parameter than CD4+CD7- in Sézary syndrome (SS).
1995-01-01 Novelli M; Quaglino P; Fierro MT; Savoia P; De Matteis A; Bernengo MG
Cell proliferation and DNA content in primary cutaneous B-cell lymphomas.
1999-01-01 Cambieri I; Ponti R; Quaglino P; Novelli M; Fierro MT; Bernengo MG
Clinic-pathologic features of sentinel lymph nodes predictive for non-sentinel lymph node involvement, disease-free survival and overall survival in melanoma patients
2010-01-01 Quaglino P; Ribero S; Macri L; Sapino A; Osella-Abate S; Grassi M; Caliendo V; Savoia P; Sapino A; Macripò G; Bernengo MG
Clonal heterogeneity in mycosis fungoides/Sézary Syndrome: incidence, relation with clinico-pathologic features and prognostic significance
2010-01-01 Fierro MT; Ponti R; Titli S; Fava P; Novelli M; Quaglino P; Bernengo MG